About: Innovative countermeasures can maintain cancer care continuity during the COVID-19 pandemic in Korea

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Innovative countermeasures can maintain cancer care continuity during the COVID-19 pandemic in Korea Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : covidontheweb.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
has title	Innovative countermeasures can maintain cancer care continuity during the COVID-19 pandemic in Korea
Creator	Lee, S Choi, Y Kim, Hong Kim, J Kim, Y Shin, S Kim, ; Kim, M.-J Lim, A.-R Park, K Yeul, Prof
Source	Elsevier; Medline; PMC; WHO
abstract	BACKGROUND: Even though Korea was known to have the highest number of coronavirus disease 19 (COVID-19) infection in the early phase of the pandemic, Korea was able to successfully flatten the curve in a short period of time without extreme measures. We compared the status of cancer management before and after COVID-19 and analyzed how cancer care continuity was maintained in Korea. PATIENTS AND METHODS: We investigated the medical records on the number of cancer diagnosis, cancer surgery, radiation therapy and scheduled chemotherapy conducted in Korea University Anam Hospital from January 1 to April 30, 2019 and from the same period in 2020. We also collected the data of metastatic cancer patients who were hospitalized due to respiratory disease. RESULTS: 1694 cancer diagnoses were made in the study period of 2019, and 1445 diagnoses in 2020 (decreased by 14.7%); the cancer surgery performed 830 and 800 cases; the set-up for radiation therapy decreased from 185 to 140 cases; the number of systemic chemotherapies for metastatic cancer patients treated in department of medical oncology increased from 2555 to 2878 cases. Among hospitalized patients, emergency center visit, intensive care unit admission, discharge after recovery and death reveal no drastic changes. CONCLUSIONS: Routine cancer care for patients with metastatic cancer has been maintained without significant difference before and after the COVID-19 pandemic. The Korean government’s innovative countermeasures in the early phase of outbreak made it possible for cancer care practitioners to provide cancer patients with regular care under the standard infection control protocol.
has issue date	2020-07-03(xsd:dateTime)
bibo:doi	10.1016/j.ejca.2020.06.021
bibo:pmid	32652443
has license	no-cc
sha1sum (hex)	12725c42c330220a05145d31a9f78af937593c9d
schema:url	https://doi.org/10.1016/j.ejca.2020.06.021
resource representing a document's title	Innovative countermeasures can maintain cancer care continuity during the COVID-19 pandemic in Korea
has PubMed Central identifier	PMC7332944
has PubMed identifier	32652443
schema:publication	Eur J Cancer
resource representing a document's body	covid:12725c42c330220a05145d31a9f78af937593c9d#body_text
is schema:about of	named entity 'number' named entity 'pandemic' named entity 'Innovative' named entity 'Innovative' named entity 'PANDEMIC' named entity 'CORONAVIRUS DISEASE' named entity 'COMPARED' named entity 'continuity' named entity 'infection' named entity 'flatten' named entity 'pandemic' named entity 'coronavirus disease' named entity 'Korea' named entity 'cancer management' named entity 'infection' named entity 'period of time' named entity 'cancer care' named entity 'Korea' named entity 'infection control' named entity 'fever' named entity 'COVID' named entity 'COVID' named entity 'quarantine' named entity 'intensive care unit' named entity 'Daegu' named entity 'self-isolation' named entity 'oncology' named entity 'COVID' named entity 'clinical features' named entity 'radiation therapy' named entity 'increased exponentially' named entity 'metastatic cancer' named entity 'chronic disease' named entity 'medical records' named entity 'medical services' named entity 'cancer management' named entity 'Centers for Disease Control & Prevention' named entity 'health care' named entity 'anti-cancer' named entity 'global pandemic' named entity 'chemotherapy' named entity 'COVID' named entity 'Korea' named entity 'fever' named entity 'Korea University' named entity 'Daegu' named entity 'WHO' named entity 'signs and symptoms' named entity 'Korea University' named entity 'COVID-19' named entity 'respiratory symptoms' named entity 'COVID-19' named entity 'chemotherapy' named entity 'COVID' named entity 'COVID-19' named entity 'COVID' named entity 'fever' named entity 'February 29' named entity 'COVID-19 pandemic crisis' named entity 'doctors, nurses' named entity 'radiation therapy' named entity 'health care' named entity 'South Korea' named entity 'self-isolation' named entity 'disease control' named entity 'cell phone' named entity 'COVID-19 outbreak' named entity 'cancer care' named entity 'COVID' named entity 'diagnostic testing' named entity 'COVID'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software